Tag: Combination therapy

Home / Combination therapy

Categories

Roche PD-1 inhibitor liver cancer combination therapy was recognized by the FDA as a breakthrough therapy

The Swiss Roche Group announced yesterday that TECENTRIQ® (atezolizumab) in combination with Avastin® (bevacizumab) has been approved by the US Food and Drug Administration (FDA) for breakthrough th...
combination-therapy

Scan the code